Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Portable CT increases chance of stroke survival and recovery

Portable CT increases chance of stroke survival and recovery

December 02, 2008

CHICAGO - New research has found that the availability of a portable eight-slice computed tomography (CT) scanner in an emergency room can significantly increase the number of stroke victims who receive a potentially life-saving treatment. Results of the study, conducted at North Shore Medical Center (NSMC)-Salem Hospital in Salem, Mass., will be presented today at the annual meeting of the Radiological Society of North America (RSNA).

"The hospital's acquisition of a portable CT scanner facilitated more rapid assessment of acute stroke patients and is anticipated to increase the number of patients to whom thrombolytic therapy can be administered," said the study's lead author, David B. Weinreb, M.D., now a resident physician in the Department of Radiology at Hospital of Saint Raphael in New Haven, Conn.




According to the National Institute of Neurological Disorders and Stroke (NINDS), stroke is the third leading cause of death in the U.S., and more than 700,000 cases of stroke are diagnosed annually. The most common kind of stroke, ischemic stroke, occurs when a blood clot blocks a blood vessel in the brain. Such strokes can be treated with thrombolytic therapy using a drug called tPA that dissolves the blockage. However, the window of opportunity to safely administer the medication is generally considered to be just three hours. Also, it is important to determine that there is no bleeding in the brain before administering tPA. One out of six strokes is caused by bleeding rather than clotting.

"tPA is usually the only shot we have at clot-induced ischemic strokes," Dr. Weinreb said. "But it needs to be administered in a closely monitored situation, because the drug can have extremely adverse effects in those patients whose strokes are instead due to bleeds."

Before a patient receives tPA, a head CT must be performed to ensure there is no bleeding in the brain. NINDS recommends that patients who arrive in the emergency room (ER) with signs of acute stroke undergo CT imaging within 25 minutes.

For the study, Dr. Weinreb and colleagues began using a portable CT scanner to assess stroke patients in the ER of NSMC-Salem Hospital. During the month prior to the acquisition of the portable scanner and for a four-month period following its installation, researchers measured how much time elapsed between a physician order for a head CT and performance of the scan.

The availability of the CT scanner in the hospital's ER reduced the time between the order and exam from 34 minutes to 15 minutes, a reduction of 54 percent. Based on simulation modeling, the researchers estimated that this improvement would increase by 86 percent the number of stroke patients able to be treated with thrombolytic therapy within the three-hour window.

According to Dr. Weinreb, most stroke patients are taken to relatively small community hospitals where access to CT scanning may be limited. When a CT scanner is available, it is not always in proximity to the ER, making transportation of critically ill patients to the radiology department both difficult and time-consuming.

"A portable eight-slice CT can be easily added and used to accurately identify a head bleed in a stroke or trauma patient," Dr. Weinreb said. "This new technology is able to solve a very important problem for a community hospital, where the majority of stroke victims are being treated."

Radiological Society of North America



Related Thrombolytic Current Events and Thrombolytic News Articles Thrombolytic Current Events and Thrombolytic News RSS Thrombolytic Current Events and Thrombolytic News RSS
Stanford study recommends change in treating pulmonary embolisms
William Kuo, MD, was the on-call interventional radiologist one Friday night three years ago when he received a call from the intensive care unit at Stanford Hospital & Clinics.

Aspirin and similar drugs may be associated with brain microbleeds in older adults
Individuals who take aspirin or other medications that prevent blood clotting by inhibiting the accumulation of platelets appear more likely to have tiny, asymptomatic areas of bleeding in the brain.

Rush University Medical Center Orthopedic Experts Examine Overhead Throwing Injuries
Baseball season is underway. With the pros, college and high school teams taking to the baseball diamonds and Little Leaguers soon to follow, orthopedic specialists at Rush University Medical Center are cautioning players to be aware of and take precautions against throwing injuries.

Patients who wake up with stroke may be candidates for clot-busters
Giving clot-busting drugs to patients who wake up with stroke symptoms appears to be as safe as giving it to those in the recommended three-hour window, according to researchers at The University of Texas Medical School at Houston.

Stroke therapy window might be extended past nine hours for some
Some patients who suffer a stroke as a result of a blockage in an artery in the brain may benefit from a clot-busting drug nine or more hours after the onset of symptoms. The findings are published in the online edition of Radiology.

WVU study demonstrates efficacy of CT perfusion in diagnosis of acute ischemic stroke
A study conducted by a team of stroke experts from West Virginia University Health Sciences Center demonstrates that CT (computed tomography) perfusion imaging - a technology which measures blood flow and is available to most hospitals - may dramatically improve fast and accurate stroke diagnosis, enabling physicians to provide more targeted care and helping avoid potentially life-threatening complications of "clot buster" therapy.

New research could save lives and millions of dollars
The Hunter Medical Research Institute (HMRI) Stroke Research Group has developed a system to fast track stroke treatment which could benefit thousands of Australian stroke patients and save millions of dollars annually.

Treatment window expanded
Patients can still benefit up to 4.5 hours after a stroke if a drug that dis-solves blood clots in the brain is administered. Thus far, three hours had been considered the useful limit for administering thrombolytic drugs.

New blood clot guidelines for pregnant women
New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies.

Avoiding Spleen Removal for Cooley's Anemia Sufferers
Researchers from Weill Cornell Medical College may have discovered the precise role of a gene in one of the world's most common blood disorders, beta-thalassemia, commonly known as Cooley's anemia.
More Thrombolytic Current Events and Thrombolytic News Articles
  Chest. Antithrombotic and Thrombolytic Therapy. (Official Publication of the American College of Chest Physicians): Volume 133, Number 6, June 2008. Supplement to Chest. 8th Edition
by Richard S. Irwin (Author)



Nattokinase Plus (100 mg, 90 capsules)

Nattokinase Plus (100 mg, 90 capsules)
by Vesta Pharmaceuticals

In the 1980s, Dr. Hiroyuki Sumi at the University of Chicago isolated the circulation-promoting enzyme in natto and called it Nattokinase, meaning enzyme from natto. Research (including two small human trials) has shown Nattokinase supports healthy blood flow by assisting in the circulatory clearing system of the body. Specifically, Nattokinase supports the fibrinolytic clearing system in the body which is responsible for healthy circulation, by helping to break down fibrin protein deposits in the bloodstream to promote and enhance healthy blood flow.

Thrombolytic Therapy for Acute Stroke (Current Clinical Neurology)

Thrombolytic Therapy for Acute Stroke (Current Clinical Neurology)
by Patrick D. Lyden (Editor)

This extensively revised and expanded second edition incorporates the knowledge gained from the widespread implementation of large rt-PA for acute stroke trials and demonstrates the power of the new technologies now available. The authors have included much new material on stroke-MRI and computed omogaraphy, and updated all chapters describing the background, use, and nuances of thrombolytic therapy. They present everything one needs to know for proper patient selection, the key to successful treatment. Practical how-to chapters guide the reader in treating acute stroke patients, both with and without thrombolytic therapy. New detailed practice cases that simulate making the rounds in a world-class stroke center prepare practitioners to be as ready as possible for their first case.

  Thrombolytic Therapy in the Treatment of Mi [VHS]
Starring: Health and Sciences Television Network



Thrombolytic Therapy for Stroke

Thrombolytic Therapy for Stroke
by Patrick D. Lyden (Editor)

UCSD Stroke Center, San Diego, CA. A text for clinicians treating patients in the first few hours after a stroke, providing all of the data necessary to understand the limitations of thrombolytic therapy. Includes protocols and case tutorials introducing the indications and contraindications of this type of therapy. DNLM: Cerebrovascular Accident--drug therapy.

  Guidelines for thrombolytics need updating.(Cardiovascular Medicine): An article from: Internal Medicine News
by Christine Kilgore (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on January 15, 2005. The length of the article is 864 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Guidelines for thrombolytics need updating.(Cardiovascular Medicine)
Author: Christine Kilgore
Publication: Internal Medicine News (Magazine/Journal)
Date: January 15, 2005
Publisher: International Medical News Group
Volume: 38 Issue: 2 Page: 62(1)

Distributed by Thomson...

  Thrombolytic Therapy for Peripheral Vascular Disease (Books)
by Anthony J. Comerota (Editor)

This comprehensive text is liberally illustrated to assist the clinician in properly identifying and treating patients requiring thrombolytic therapy. Authoritatively written, this practical text addresses modern therapies for deep acute venous thrombosis, primary and secondary axillo-subclavian vein thrombosis, acute limb ischemia, chronic arterial occlusion, and occluded access grafts. It also covers a complete range of lytic agents including streptokinase, urokinase, acylated streptokinase, prourokinase, recombinant tissue plasminogen activator and a new kinase for preventing strokes.

  Review of Thrombolytic Therapy and Thromboembolic Disease
by William R. Bell (Editor), Arthur A. Sasahara (Editor), Tim Phelps (Editor)



  Proceedings of the Conference on Thrombolytic Agents (April 8-9, 1960)
by Harold R. Roberts (Editor), J. Dieter Geratz (Editor)

Proceedings of the conference held April 8-9, 1960, in Chicago, Illinois. Sponsored by the Hematology Study Section, Public Health Service.

  Neuroprotective and thrombolytic agents: advances in stroke treatment.: An article from: Journal of Neuroscience Nursing
by Nanette Hock (Author)

This digital document is an article from Journal of Neuroscience Nursing, published by American Association of Neuroscience Nurses on June 1, 1998. The length of the article is 7464 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

From the supplier: Early treatment of ischemic stroke may include neuroprotective agents and thrombolytic drugs to reduce the extent of neuronal damage. Neuroprotective agents under investigation block the glutamate cascade, inhibit calcium flux, antagonize opioid receptors, or block nitric oxide formation or free radical activity. Thrombolytics, such as streptokinase,...

© 2009 BrightSurf.com